[8-K] SANUWAVE Health, Inc. Reports Material Event

Rhea-AI Filing Summary

SANUWAVE Health, Inc. (SNWV) filed an Form 8-K dated 8-Aug-2025 under Item 2.02 to furnish—not file—a press release announcing its financial results for the quarter ended 30-Jun-2025. The detailed numbers are contained in Exhibit 99.1, which is not reproduced in the body of this report. Management will host a business-update conference call on 8-Aug-2025 at 8:30 a.m. EST; supporting materials are available on the investor section of the company’s website. The filing also lists Exhibit 104, which embeds the cover-page XBRL tags, and confirms that the information is excluded from Section 18 liability and is not incorporated by reference into other Securities Act filings.

Insights

Financial Analyst

TL;DR: No metrics disclosed; 8-K simply furnishes press release and call details—impact neutral until figures are reviewed.

The filing is procedural, alerting investors to the availability of Q2 2025 results via an attached press release (Ex. 99.1) and a same-day conference call. Because the 8-K itself lacks revenue, EPS, margin or guidance data, it neither alters valuation models nor provides insight into operating trends. Materiality will depend on the still-unseen numbers. Treatment as “furnished” (not “filed”) limits liability and indicates management’s intent to disseminate information quickly without integrating it into securities-law representations.

FALSE000141766300014176632025-08-082025-08-08

1

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) August 8, 2025

SANUWAVE Health, Inc.

(Exact name of registrant as specified in its charter)

Nevada			000-52985			20-1176000
(State or other jurisdiction of incorporation)			(Commission File Number)			(IRS Employer Identification No.)

11495 Valley View Road,			Eden Prairie,			Minnesota			55344
(Address of principal executive offices)									(Zip Code)

Registrant’s telephone number, including area code (952) 656-1029

N/A

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

☐			Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐			Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐			Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐			Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:

Title of each class			Trading Symbol(s)			Name of each exchange on which registered
Common stock, par value $0.001 per share			SNWV			The Nasdaq Stock Market LLC

Indicate by check mark whether the registration is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 or Rule 12b-2 of the Securities Exchange Act of 1934.

Emerging growth company o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

1

2

Item 2.02              Results of Operations and Financial Condition.

On August 8, 2025, Sanuwave Health, Inc., a Nevada corporation (the “Company”), issued a press release announcing its financial results for the second quarter ended June 30, 2025. As previously announced, a business update via conference call will occur on August 8, 2025 at 8:30 am EST. Materials are provided on the Company’s website at www.sanuwave.com/investors.

The information in this Item 2.02 of this Current Report on Form 8-K and the exhibit attached hereto shall not be deemed to be “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing.

Item 9.01              Financial Statements and Exhibits.

(d)Exhibits.

Exhibit No.						Description
99.1						Press Release dated August 8, 2025
104						Cover Page Interactive Data File--the cover page XBRL tags are embedded within the Inline XBRL document.

2

3

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

			SANUWAVE HEALTH, INC.
Dated: August 8, 2025			By:			/s/ Peter Sorensen
			Name:			Peter Sorensen
			Title:			Chief Financial Officer

3

FAQ

What event did SANUWAVE Health (SNWV) report in its August 8 2025 Form 8-K?

The company furnished a press release announcing its Q2 2025 financial results and related conference-call details.

When is SNWV's Q2 2025 earnings conference call scheduled?

The call is set for August 8 2025 at 8:30 a.m. EST.

Which exhibit contains the Q2 2025 press release for SNWV?

Exhibit 99.1 includes the full press release dated August 8 2025.

Does the 8-K filing include detailed financial statements?

No. The 8-K references the press release; no financial tables appear within the body of the report.

How is the Item 2.02 information treated under SEC rules?

It is furnished, not filed, meaning it is excluded from Section 18 liability and is not automatically incorporated into other filings.